Monika E. Hegi

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 02, 2026

Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas.

Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas.

Journal: Neuro-oncology
Published: October 21, 2025

Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Journal: Neuro-oncology
Published: August 19, 2025

Tumor-derived aminopeptidase N promotes early stages of brain metastatic colonization.

Tumor-derived aminopeptidase N promotes early stages of brain metastatic colonization.

Journal: Cell reports
Published: May 22, 2025

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.

Journal: Neuro-oncology
Published: April 12, 2025

Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment.

Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment.

Journal: Neuro-oncology advances
Published: March 05, 2025

No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients.

No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients.

Journal: Neuro-oncology
Published: June 24, 2024

Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors.

Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors.

Journal: Immunity
Published: June 19, 2024

Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative.

Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative.

Journal: Neuro-oncology
Published: September 22, 2023

Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence.

Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence.

Journal: Cancer cell
Published: June 21, 2023

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.

Journal: Neuro-oncology
Published: June 06, 2023

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 29, 2023
Showing 1-12 of 91

Last Updated: 09/26/2026